AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8017151 — intervention group
Group type: EXPERIMENTAL
Intervention: Device 3
Number of subjects: 72
Study 1913037 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound
Number of subjects: 19
Study 1913037 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound (including vein stenosis)
Number of subjects: 19
Study 1913037 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour Doppler ultrasound (normal results)
Number of subjects: 19
Study 1913037 — intervention group
Group type: COMPARATOR
Intervention: Contrast venography
Number of subjects: 19
Study 97779 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide
Number of subjects: 47
Study 97779 — intervention group
Group type: EXPERIMENTAL
Intervention: Single morning dose of Loperamide
Number of subjects: 47
Study 97779 — intervention group
Group type: EXPERIMENTAL
Intervention: Second bedtime dose of Loperamide
Number of subjects: 47
Study 31162002 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke smoking cessation intervention
Number of subjects: 22
Study 31162002 — intervention group
Group type: COMPARATOR
Intervention: Usual smoking cessation services
Number of subjects: 22
Study 27884071 — intervention group
Group type: EXPERIMENTAL
Intervention: UCAN (online Theory of Planned Behaviour-based PA behaviour change programme)
Number of subjects: 95
Study 25415314 — intervention group
Group type: EXPERIMENTAL
Intervention: Pig model
Number of subjects: 50
Study 23807564 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide alone
Number of subjects: 24
Study 23807564 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide with flucloxacillin
Number of subjects: 24
Study 23807564 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin
Number of subjects: 24
Study 21440713 — intervention group
Group type: EXPERIMENTAL
Intervention: High-power pain threshold ultrasound (HPPTUS) therapy
Number of subjects: 49
Study 21440713 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic injection (TrP)
Number of subjects: 49
Study 20048767 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional slides
Number of subjects: 0
Study 18073467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen levels in patients aged <60 years
Number of subjects: 23272
Study 18073467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen levels in patients aged <60 years with below median normal glucose levels
Number of subjects: 23272
Study 18073467 — intervention group
Group type: COMPARATOR
Intervention: Fibrinogen levels in individuals with impaired glucose tolerance or diabetes
Number of subjects: 23272
Study 14760960 — intervention group
Group type: EXPERIMENTAL
Intervention: IVMP-IVIg
Number of subjects: 19
Study 14760960 — intervention group
Group type: COMPARATOR
Intervention: IVMP
Number of subjects: 19
Study 11677455 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonography (US) in HIV+ children
Number of subjects: 22
Study 11677455 — intervention group
Group type: COMPARATOR
Intervention: Sonography (US) in HIV- children (control group)
Number of subjects: 22
Study 11677455 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of US exams before and after HAART
Number of subjects: 22
Study 9648120 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Portable Mental Status Questionnaire
Number of subjects: 292
Study 9648120 — intervention group
Group type: COMPARATOR
Intervention: Caregiver information about daily activities and performance ability
Number of subjects: 292
Study 8205407 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 53
Study 8205407 — intervention group
Group type: COMPARATOR
Intervention: Omnivorous diet
Number of subjects: 53
Study 2610619 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% MVC clenching with 30s rest
Number of subjects: 10
Study 2610619 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% MVC clenching with 120s rest
Number of subjects: 10
Study 2610619 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% MVC clenching with 300s rest
Number of subjects: 10
Study 2610619 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% MVC clenching
Number of subjects: 10
Study 2610619 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-contraction blood flow
Number of subjects: 10
Study 1092725 — intervention group
Group type: EXPERIMENTAL
Intervention: Stelazine (STEL) 50 mg/day
Number of subjects: 0
Study 1092725 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxapine (LOX) 100 mg/day for four weeks
Number of subjects: 0
Study 1092725 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study 11317476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 2 mg b.i.d.
Number of subjects: 18
Study 11317476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg b.i.d.
Number of subjects: 18
Study 11317476 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 12 mg b.i.d.
Number of subjects: 18
Study 30247939 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Well, Think Well (SWTW) group intervention
Number of subjects: 35
Study 30247939 — intervention group
Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 35
Study 30268163 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen mixture plus conventional pain treatment
Number of subjects: 90
Study 30268163 — intervention group
Group type: COMPARATOR
Intervention: Oxygen plus conventional pain treatment
Number of subjects: 90
Study 26753892 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine 25 mg once daily for 8 weeks
Number of subjects: 83
Study 24318743 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phenoxodiol (PXD) plus AUC2-carboplatin
Number of subjects: 142
Study 24318743 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus AUC2-carboplatin
Number of subjects: 142
Study 22229304 — intervention group
Group type: EXPERIMENTAL
Intervention: Two portions of salmon per week
Number of subjects: 0
Study 22229304 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet low in oily fish)
Number of subjects: 0
Study 20186996 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal laparoscopic repair (TEP)
Number of subjects: 1370
Study 20186996 — intervention group
Group type: COMPARATOR
Intervention: Open repair by the Lichtenstein procedure
Number of subjects: 1370
Study 17505730 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading
Number of subjects: 40
Study 17505730 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 40
Study 17505730 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with reading
Number of subjects: 40
Study 17505730 — intervention group
Group type: COMPARATOR
Intervention: Control group (G5 - not sustaining arterial hypertension and not suffering from glaucoma or ocular hypertension)
Number of subjects: 40
Study 15737962 — intervention group
Group type: EXPERIMENTAL
Intervention: Cypher stent
Number of subjects: 500
Study 12399193 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micro g MPL
Number of subjects: 129
Study 12399193 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micro g MPL/AlPO(4)
Number of subjects: 129
Study 12399193 — intervention group
Group type: COMPARATOR
Intervention: MPL-containing vaccine
Number of subjects: 129
Study 9794569 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5‐10 mg once daily)
Number of subjects: 27
Study 9794569 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine retard (10‐40 mg twice daily)
Number of subjects: 27
Study 9794569 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 27
Study 9794569 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 27
Study 7655643 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) 100 micrograms acute test
Number of subjects: 20
Study 7655643 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) administration (300 to 600 micrograms/day for 1 month)
Number of subjects: 20
Study 7655643 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) administration (300 to 600 micrograms/day for 6 months)
Number of subjects: 20
Study 7655643 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) administration
Number of subjects: 20
Study 2782327 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilmenidine 1 mg
Number of subjects: 40
Study 2782327 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 40
Study 1090415 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg indapamide daily
Number of subjects: 18
Study 1090415 — intervention group
Group type: COMPARATOR
Intervention: 40 mg frusemide daily
Number of subjects: 18
Study 31166858 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressing
Number of subjects: 240
Study 31166858 — intervention group
Group type: COMPARATOR
Intervention: Control (neutral dressing)
Number of subjects: 240
Study 28732289 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy for PTSD (CT-PTSD)
Number of subjects: 0
Study 28732289 — intervention group
Group type: COMPARATOR
Intervention: Emotion-focused supportive therapy
Number of subjects: 0
Study 28732289 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 0
Study 28732289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive CT-PTSD (delivered over 7 days)
Number of subjects: 0
Study 25641639 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH administration (0.50 ± 0.06 mg/kg · wk) for 11.1 ± 4.8 months
Number of subjects: 15
Study 24377964 — intervention group
Group type: EXPERIMENTAL
Intervention: Pack-and-fill protocol (HP)
Number of subjects: 8
Study 24377964 — intervention group
Group type: COMPARATOR
Intervention: Shoulder pad removal (HS)
Number of subjects: 8
Study 22781160 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathways (CPs)
Number of subjects: 14
Study 22781160 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 14
Study 19232612 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 20
Study 19232612 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic occlusion of uterine vessels (LOUV)
Number of subjects: 20
Study 17720777 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglustat 100 mg with food
Number of subjects: 24
Study 17720777 — intervention group
Group type: COMPARATOR
Intervention: Miglustat 100 mg without food
Number of subjects: 24
Study 15377319 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-220453 40 mg
Number of subjects: 15
Study 15377319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 11704024 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with postoperative subconjunctival 5‐fluorouracil injections
Number of subjects: 213
Study 11704024 — intervention group
Group type: COMPARATOR
Intervention: Standard trabeculectomy
Number of subjects: 213
Study 11704024 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with one-layer conjunctiva-Tenon capsule closure
Number of subjects: 213
Study 11704024 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with two-layer closure
Number of subjects: 213
Study 11704024 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy located inferiorly
Number of subjects: 213
Study 11704024 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy located superiorly
Number of subjects: 213
Study 11704024 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with leaks
Number of subjects: 213
Study 9059564 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA plus insulin infusion
Number of subjects: 10
Study 9059564 — intervention group
Group type: COMPARATOR
Intervention: DHEA infusion alone
Number of subjects: 10
Study 7971539 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative teaching program
Number of subjects: 0
Study 7971539 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative teaching)
Number of subjects: 0
Study 3309658 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin
Number of subjects: 955
Study 3309658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955
Study 31273570 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 30
Study 31273570 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 30
Study 31273570 — intervention group
Group type: COMPARATOR
Intervention: Steel bur
Number of subjects: 30
Study 30056028 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizagliflozin 5 mg
Number of subjects: 258
Study 30056028 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizagliflozin 10 mg
Number of subjects: 258
Study 30056028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 28647631 — intervention group
Group type: EXPERIMENTAL
Intervention: FS Grifols
Number of subjects: 167
Study 28647631 — intervention group
Group type: COMPARATOR
Intervention: Manual Compression (MC)
Number of subjects: 167
Study 26289092 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulated external fixator
Number of subjects: 33
Study 26289092 — intervention group
Group type: COMPARATOR
Intervention: Rigid knee bracing (control)
Number of subjects: 33
Study 22872648 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN first (180 μg/week for 24 weeks followed by LdT 600 mg/day for 24 weeks)
Number of subjects: 30
Study 22872648 — intervention group
Group type: EXPERIMENTAL
Intervention: LdT first (600 mg/day for 24 weeks followed by PEG‐IFN 180 μg/week for 24 weeks)
Number of subjects: 30
Study 21122961 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐times‐weekly in‐center daily hemodialysis (1.5‐2.75 h/session)
Number of subjects: 332
Study 21122961 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐times‐weekly home nocturnal hemodialysis (6‐8 h/session)
Number of subjects: 332
Study 21122961 — intervention group
Group type: COMPARATOR
Intervention: Conventional 3‐times‐weekly in‐center hemodialysis
Number of subjects: 332
Study 18936283 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivoglitazone
Number of subjects: 0
Study 18936283 — intervention group
Group type: EXPERIMENTAL
Intervention: Models developed prior to the second phase II study
Number of subjects: 0
Study 16580291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal glyceryl trinitrate plus dinoprostone
Number of subjects: 196
Study 16580291 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus dinoprostone
Number of subjects: 196
Study 12728377 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic treatment
Number of subjects: 200
Study 12728377 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Open surgery)
Number of subjects: 200
Study 10708324 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning with smoking-related cues and neutral stimuli (two colored cards indicating nicotine intake)
Number of subjects: 40
Study 10708324 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of smoking-related cues
Number of subjects: 40
Study 9298772 — intervention group
Group type: EXPERIMENTAL
Intervention: Marathon run (MR)
Number of subjects: 7
Study 9298772 — intervention group
Group type: EXPERIMENTAL
Intervention: Triathlon run (TR)
Number of subjects: 7
Study 9298772 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated run (IR)
Number of subjects: 7
Study 8509578 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray 200 micrograms once daily
Number of subjects: 466
Study 8509578 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray 100 micrograms twice daily
Number of subjects: 466
Study 8509578 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray 168 micrograms twice daily
Number of subjects: 466
Study 8509578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 466
Study 3803214 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of training per day at 70% of submaximal performance for six weeks
Number of subjects: 25
Study 3803214 — intervention group
Group type: COMPARATOR
Intervention: Bedrest
Number of subjects: 25
Study 31685694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 50
Study 30572545 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous rocuronium infusion (5 mcg/kg/min)
Number of subjects: 80
Study 30572545 — intervention group
Group type: COMPARATOR
Intervention: Bolus of rocuronium (0.1 mg/kg) as needed
Number of subjects: 80
Study 30572545 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study 27216303 — intervention group
Group type: EXPERIMENTAL
Intervention: PITA with CO2 laser
Number of subjects: 92
Study 27216303 — intervention group
Group type: EXPERIMENTAL
Intervention: PITA with debrider
Number of subjects: 92
Study 27216303 — intervention group
Group type: COMPARATOR
Intervention: Tonsillectomy and adenoidectomy (TA)
Number of subjects: 92
Study 24797607 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-handed tracheal intubation
Number of subjects: 80
Study 24797607 — intervention group
Group type: COMPARATOR
Intervention: Air-Q assisted fibreoptic-guided tracheal intubation
Number of subjects: 80
Study 22888158 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-conferencing support
Number of subjects: 83
Study 22888158 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support
Number of subjects: 83
Study 22888158 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study 21077561 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory interruption with the primary task visible
Number of subjects: 0
Study 21077561 — intervention group
Group type: COMPARATOR
Intervention: Auditory interruption with a blank screen occluding the primary task
Number of subjects: 0
Study 21077561 — intervention group
Group type: COMPARATOR
Intervention: Visual interruption occluding the primary task
Number of subjects: 0
Study 18502247 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 134
Study 18502247 — intervention group
Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 134
Study 18502247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 134
Study 15737447 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral cane
Number of subjects: 14
Study 15737447 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral cane
Number of subjects: 14
Study 15737447 — intervention group
Group type: COMPARATOR
Intervention: Unaided gait
Number of subjects: 14
Study 11606830 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) - IV bolus dose of 15 mg/kg followed by a constant IV infusion of 10 mg/kg/hour until 12 hours after tourniquet deflation
Number of subjects: 40
Study 11606830 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin - 0.3 mg/kg administered similarly to TA
Number of subjects: 40
Study 11606830 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin
Number of subjects: 40
Study 11606830 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA)
Number of subjects: 40
Study 11606830 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 9539254 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU Vitamin D3 for 5 days
Number of subjects: 44
Study 9539254 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU Vitamin D3 for 5 days
Number of subjects: 44
Study 9539254 — intervention group
Group type: COMPARATOR
Intervention: No Vitamin D3 for 5 days
Number of subjects: 44
Study 8016790 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (100 micrograms/puff, two puffs three times daily for eight weeks)
Number of subjects: 33
Study 8016790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 8016790 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide
Number of subjects: 33
Study 2642730 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (EXT)
Number of subjects: 123
Study 2642730 — intervention group
Group type: COMPARATOR
Intervention: Halsted radical mastectomy (RDL)
Number of subjects: 123
Study 2642730 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (EXT) in patients with central-medial tumors
Number of subjects: 123
Study 2642730 — intervention group
Group type: COMPARATOR
Intervention: Halsted radical mastectomy (RDL) in patients with central-medial tumors
Number of subjects: 123
Study 2642730 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (EXT) in patients with lateral tumors
Number of subjects: 123
Study 2642730 — intervention group
Group type: COMPARATOR
Intervention: Halsted radical mastectomy (RDL) in patients with lateral tumors
Number of subjects: 123
Study 1113783 — intervention group
Group type: EXPERIMENTAL
Intervention: Television consultations
Number of subjects: 0
Study 1113783 — intervention group
Group type: COMPARATOR
Intervention: Telephone consultations
Number of subjects: 0
Study 6938526 — intervention group
Group type: EXPERIMENTAL
Intervention: Test amalgams contoured to remove overhangs
Number of subjects: 26
Study 6938526 — intervention group
Group type: COMPARATOR
Intervention: Control amalgams with subgingival overhanging margins
Number of subjects: 26
Study 30084962 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive models for gene expression using ChIP‐seq and DNase1‐seq data
Number of subjects: 0
Study 30084962 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction approaches for both data types
Number of subjects: 0
Study 30084962 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality control measures
Number of subjects: 0
Study 27414956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Conflict training
Number of subjects: 3
Study 27414956 — intervention group
Group type: COMPARATOR
Intervention: Low-Conflict training
Number of subjects: 3
Study 27414956 — intervention group
Group type: COMPARATOR
Intervention: 3-Back training
Number of subjects: 3
Study 29231364 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with thunder-fire moxibustion
Number of subjects: 80
Study 29231364 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 80
Study 24410736 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysate IL-6 concentration
Number of subjects: 88